Literature DB >> 2966573

Transluminal atherectomy for occlusive peripheral vascular disease.

J B Simpson1, M R Selmon, G C Robertson, P R Cipriano, W G Hayden, D E Johnson, T J Fogarty.   

Abstract

Sixty-one patients with occlusive peripheral vascular disease were treated with transluminal atherectomy, a catheter-mediated technique for removal of atheroma. The technique was performed using 7Fr, 9Fr or 11Fr atherectomy catheters. Mean percent diameter stenosis was reduced from 71 to 23%, by removal of 831 atheromatous specimens in 949 passes of the cutting element through 136 stenoses in 61 patients. All specimens removed were sent for histopathologic examination to determine the components of the atheroma removed, which differed for specimens removed from original vs restenotic lesions. Percent stenosis was reduced to less than 45% in 118 of 136 stenoses (87%). Complications included 1 thrombus, which resolved after intraarterial infusion of streptokinase and 1 probable distal embolization without sequelae. Three angiographic dissections occurred without impairment of blood flow. There were no instances of acute occlusion, vascular spasm or vessel perforation. Six-month follow-up angiography was performed showing that patients who had a residual stenosis less than 30% after initial atherectomy had a lower restenosis rate (18%) than patients with initial residual stenoses greater than 30% (52%); this result demonstrated the importance of performing more complete atherectomy. Transluminal atherectomy appears to be an effective, predictable and safe method for removing occlusive atheromatous deposits from peripheral arteries.

Entities:  

Mesh:

Year:  1988        PMID: 2966573     DOI: 10.1016/s0002-9149(88)80040-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

Review 1.  Current techniques for infrainguinal arterial reconstruction.

Authors:  A Whittemore
Journal:  Jpn J Surg       Date:  1990-11

2.  Laser ablation and the need for intra-arterial imaging.

Authors:  C Borst; R Rienks; W P Mali; L van Erven
Journal:  Int J Card Imaging       Date:  1989

3.  Clinical applications of intravascular ultrasound imaging in atherectomy.

Authors:  P G Yock; D T Linker; N W White; M H Rowe; M R Selmon; G C Robertson; T Hinohara; J B Simpson
Journal:  Int J Card Imaging       Date:  1989

4.  Does the Kensey catheter keep a coaxial position inside the arterial lumen? An in-vitro angioscopic study.

Authors:  A A Gehani; A Davies; K Stoodley; S Ashley; S G Brook; M R Rees
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Jul-Aug       Impact factor: 2.740

5.  Intravascular ultrasound imaging for guidance of atherectomy and other plaque removal techniques.

Authors:  P G Yock; P J Fitzgerald; K Sudhir; D T Linker; W White; A Ports
Journal:  Int J Card Imaging       Date:  1991

6.  Percutaneous transluminal atherectomy: preliminary results.

Authors:  G Wilms; P Pauwels; P Peene; A L Baert; J Vermylen; A Nevelsteen; R Suy
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Feb-Mar       Impact factor: 2.740

7.  Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries.

Authors:  T N Wight; S Lara; R Riessen; R Le Baron; J Isner
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

8.  Evaluation of the pullback atherectomy catheter in the treatment of lower limb vascular disease.

Authors:  S Grubnic; S D Heenan; T M Buckenham; A M Belli
Journal:  Cardiovasc Intervent Radiol       Date:  1996 May-Jun       Impact factor: 2.740

Review 9.  Intravascular ultrasound imaging of peripheral arteries as an adjunct to balloon angioplasty and atherectomy.

Authors:  Y Korogi; T Hirai; M Takahashi
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jan-Feb       Impact factor: 2.740

Review 10.  [Percutaneous mechanical atherectomy for treatment of peripheral arterial occlusive disease].

Authors:  A Buecker; P Minko; A Massmann; M Katoh
Journal:  Radiologe       Date:  2010-01       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.